Skip Navigation

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (72)
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Enevoldson, T. P.
Right arrow Articles by Harding, A. E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Enevoldson, T. P.
Right arrow Articles by Harding, A. E.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Brain, Vol. 117, No. 3, 445-460, 1994
© 1994 Guarantors of Brain


research-article

Autosomal dominant cerebellar ataxia with pigmentary macular dystrophy. A clinical and genetic study of eight familes

T. P. Enevoldson1, M. D. Sanders1 and A. E. Harding1,2,

1National Hospital for Neurology and Neurosurgery London, UK 2Department of Clinical Neurology, Institute of Neurology London, UK

Correspondence to: Correspondence to: Professor A. E. Harding, Institute of Neurology, Queen Square, London WCIN 3BG, UK

We describe 54 members of eitht families with a distinct autosomal dominant cerebellar ataxia associated with visual failure secondary to a pigmentary macular dystrophy. The presenting symptom was ataxia in two-thirds of patients and visual failure or both in the remainder. The macular abnormalities were often subtle in early cases, even in some with moderately reduced visual acuity. Other neurological features included pyramidal tract signs and a supranuclear ophthalmoplegia with progressive saccadic palsy. Ages of onset and clinical course were very variable, even within families, and included a rapidly progressive, infantile-onset phenotype. Pedigree analysis showed the existence of non-manifesting obligate carriers and anticipation in the offspring of affected fathers; transmission of the disease to severe, infantile-onset cases was always from an affected father. Similar genetic phenomena have been reported in myotonic dystrophy and Huntington's disease and it is likely that the gene mutation in this condition will similarly consist of an unstable trinucleotide repeat expansion.

dominant ataxia; maculopathy; anticipaton

Received July 19, 1993. Revised January 6, 1994. Accepted February 2, 1994.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
J. Neurol. Neurosurg. PsychiatryHome page
Y Saito, K Matsumura, S Shimizu, Y Ichikawa, K Ochiai, J Goto, S Tsuji, and T Shimizu
Pigmentary macular dystrophy in spinocerebellar ataxia type 1.
J. Neurol. Neurosurg. Psychiatry, November 1, 2006; 77(11): 1293 - 1293.
[Full Text] [PDF]


Home page
Genes Dev.Home page
B. E. Riley and H. T Orr
Polyglutamine neurodegenerative diseases and regulation of transcription: assembling the puzzle.
Genes & Dev., August 15, 2006; 20(16): 2183 - 2192.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
J. Taylor, S. K. Grote, J. Xia, M. Vandelft, J. Graczyk, L. M. Ellerby, A. R. La Spada, and R. Truant
Ataxin-7 Can Export from the Nucleus via a Conserved Exportin-dependent Signal
J. Biol. Chem., February 3, 2006; 281(5): 2730 - 2739.
[Abstract] [Full Text] [PDF]


Home page
Hum Mol GenetHome page
S. Chen, G.-H. Peng, X. Wang, A. C. Smith, S. K. Grote, B. L. Sopher, and A. R. La Spada
Interference of Crx-dependent transcription by ataxin-7 involves interaction between the glutamine regions and requires the ataxin-7 carboxy-terminal region for nuclear localization
Hum. Mol. Genet., January 1, 2004; 13(1): 53 - 67.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
G. A. Garden, R. T. Libby, Y.-H. Fu, Y. Kinoshita, J. Huang, D. E. Possin, A. C. Smith, R. A. Martinez, G. C. Fine, S. K. Grote, et al.
Polyglutamine-Expanded Ataxin-7 Promotes Non-Cell-Autonomous Purkinje Cell Degeneration and Displays Proteolytic Cleavage in Ataxic Transgenic Mice
J. Neurosci., June 15, 2002; 22(12): 4897 - 4905.
[Abstract] [Full Text] [PDF]


Home page
BrainHome page
G. Cancel, C. Duyckaerts, M. Holmberg, C. Zander, G. Yvert, A.-S. Lebre, M. Ruberg, B. Faucheux, Y. Agid, E. Hirsch, et al.
Distribution of ataxin-7 in normal human brain and retina
Brain, December 1, 2000; 123(12): 2519 - 2530.
[Abstract] [Full Text] [PDF]


Home page
Hum Mol GenetHome page
G. Yvert, K. S. Lindenberg, S. Picaud, G. B. Landwehrmeyer, J.-A. Sahel, and J.-L. Mandel
Expanded polyglutamines induce neurodegeneration and trans-neuronal alterations in cerebellum and retina of SCA7 transgenic mice
Hum. Mol. Genet., October 1, 2000; 9(17): 2491 - 2506.
[Abstract] [Full Text] [PDF]


Home page
Arch NeurolHome page
W. Gu, Y. Wang, X. Liu, B. Zhou, Y. Zhou, and G. Wang
Molecular and Clinical Study of Spinocerebellar Ataxia Type 7 in Chinese Kindreds
Arch Neurol, October 1, 2000; 57(10): 1513 - 1518.
[Abstract] [Full Text] [PDF]


Home page
Arch OphthalmolHome page
T. Abe, T. Tsuda, M. Yoshida, Y. Wada, T. Kano, Y. Itoyama, and M. Tamai
Macular Degeneration Associated With Aberrant Expansion of Trinucleotide Repeat of the SCA7 Gene in 2 Japanese Families
Arch Ophthalmol, October 1, 2000; 118(10): 1415 - 1421.
[Abstract] [Full Text] [PDF]


Home page
J. Neurol. Neurosurg. PsychiatryHome page
G. MODI
Morphological abnormalities of hepatic mitochondria in two patients with spinocerebellar ataxia type 7
J. Neurol. Neurosurg. Psychiatry, March 1, 2000; 68(3): 393 - 394.
[Full Text] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.